Article
96 shRNAs designed for maximal coverage of HIV-1 variants.
Retrovirology - 4 Jun 2009
McIntyre Glen John, Groneman Jennifer Lynne, Yu Yi-Hsin, Jaramillo Angel, Shen Sylvie, Applegate Tanya Lynn
Abstract excerpt
BACKGROUND: The RNA interference (RNAi) pathway is a mechanism of gene-suppression with potential gene therapy applications for treating viral disease such as HIV-1. The most suitable inducer of RNAi for this application is short hairpin RNA (shRNA) although it is limited to suppressing a single target. A successful anti-HIV-1 therapy will require combinations of multiple highly active, highly conserved shRNAs to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
